Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping Mao

Showing results (451-460 of 565) with videos related to

Pageof 57
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2020
Combining tumor response and personalized risk assessment: Potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy eraWei-Jie Luo, Wen-Qing Zou, Shao-Bo Liang, et al.
Oral Oncology|March 31, 2018
Optimizing the induction chemotherapy regimen for patients with locoregionally advanced nasopharyngeal Carcinoma: A big-data intelligence platform-based analysisHao Peng, Ling-Long Tang, Bin-Bin Chen, et al.
Scientific Reports|November 14, 2015
Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapyXiao-Jing Du, Ling-Long Tang, Lei Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2015
Comorbidity predicts poor prognosis in nasopharyngeal carcinoma: development and validation of a predictive score modelRui Guo, Xiao-Zhong Chen, Lei Chen, et al.
Theranostics|November 1, 2023
Erratum: Long non-coding RNA DANCR stabilizes HIF-1α and promotes metastasis by interacting with NF90/NF45 complex in nasopharyngeal carcinoma: ErratumXin Wen, Xu Liu, Yan-Ping Mao, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2019
Plasma Epstein-Barr Virus DNA Load After Induction Chemotherapy Predicts Outcome in Locoregionally Advanced Nasopharyngeal CarcinomaCheng-Long Huang, Zheng-Qiang Sun, Rui Guo, et al.
Theranostics|September 16, 2017
Genomic Analysis of Tumor Microenvironment Immune Types across 14 Solid Cancer Types: Immunotherapeutic ImplicationsYu-Pei Chen, Yu Zhang, Jia-Wei Lv, et al.
Stem Cells (Dayton, Ohio)|February 14, 2013
MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cellsKaushal Joshi, Yeshavanth Banasavadi-Siddegowda, Xiaokui Mo, et al.
Oncotarget|April 13, 2016
Implication of comorbidity on the initiation of chemotherapy and survival outcomes in patients with locoregionally advanced nasopharyngeal carcinomaRui Guo, Yan-Ping Mao, Lei Chen, et al.
Cancer Research|February 19, 2013
Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunityTae Heung Kang, Chih-Ping Mao, Sung Yong Lee, et al.
Pageof 57

Showing results (451-460 of 565) with videos related to

Sort By:
Pageof 57
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2020
Combining tumor response and personalized risk assessment: Potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy eraWei-Jie Luo, Wen-Qing Zou, Shao-Bo Liang, et al.
Oral Oncology|March 31, 2018
Optimizing the induction chemotherapy regimen for patients with locoregionally advanced nasopharyngeal Carcinoma: A big-data intelligence platform-based analysisHao Peng, Ling-Long Tang, Bin-Bin Chen, et al.
Scientific Reports|November 14, 2015
Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapyXiao-Jing Du, Ling-Long Tang, Lei Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2015
Comorbidity predicts poor prognosis in nasopharyngeal carcinoma: development and validation of a predictive score modelRui Guo, Xiao-Zhong Chen, Lei Chen, et al.
Theranostics|November 1, 2023
Erratum: Long non-coding RNA DANCR stabilizes HIF-1α and promotes metastasis by interacting with NF90/NF45 complex in nasopharyngeal carcinoma: ErratumXin Wen, Xu Liu, Yan-Ping Mao, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2019
Plasma Epstein-Barr Virus DNA Load After Induction Chemotherapy Predicts Outcome in Locoregionally Advanced Nasopharyngeal CarcinomaCheng-Long Huang, Zheng-Qiang Sun, Rui Guo, et al.
Theranostics|September 16, 2017
Genomic Analysis of Tumor Microenvironment Immune Types across 14 Solid Cancer Types: Immunotherapeutic ImplicationsYu-Pei Chen, Yu Zhang, Jia-Wei Lv, et al.
Stem Cells (Dayton, Ohio)|February 14, 2013
MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cellsKaushal Joshi, Yeshavanth Banasavadi-Siddegowda, Xiaokui Mo, et al.
Oncotarget|April 13, 2016
Implication of comorbidity on the initiation of chemotherapy and survival outcomes in patients with locoregionally advanced nasopharyngeal carcinomaRui Guo, Yan-Ping Mao, Lei Chen, et al.
Cancer Research|February 19, 2013
Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunityTae Heung Kang, Chih-Ping Mao, Sung Yong Lee, et al.
Pageof 57